🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dry Needlig Vesus Tecartherapy in Low-back Pain Treatment

RecruitingNAAges 18 Years - 65 YearsAllUniversity of Alcala
NCT05422040 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Introduction: Diathermy is a new tool that could help subjects with chronic low back pain (CLBP), with no studies having compared it to other interventions already investigated such as dry needling. Hypothesis: Diathermy is more effective than dry needling in improving pain intensity in the short term in subjects with CLBP. Design: randomised controlled trial Methods: We will conduct a convenience sampling, with subjects receiving 2 treatment sessions with diathermy or dry needling, according to allocation. Subjects will be assessed at baseline, 1 week, 1 month and 3 months after treatment for pain intensity, disability, kinesiophobia and catastrophizing. Analysis of variance (ANOVA) and moderation analysis will be performed to evaluate the results, with 95% confidence intervals (CI).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 65 years. * Chronic non-specific low back pain. * Duration of pain of more than 6 weeks. Exclusion Criteria: * Neurological signs or symptoms. * Radicular pain. * Radiating pain below the knee. * Belonephobia. * Traumatic processes and/or surgeries in the lumbar region in the last year. * Having received physiotherapy treatment in the last 3 months. * Systemic diseases such as cancer, rheumatic diseases, neurological diseases.
💊

What it tests

  • Dry needling
  • Tecartherapy treatment
📍

Where

1 site
Centro Investigación Fisioterapia y Dolor
Alcalá de Henares, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy